NCT06022640

Brief Summary

Infertility affects married adults, and In Vitro Fertilization (IVF) is an Assisted Reproductive Technology (ART) that can be treated. Women undergoing IVF are more likely to experience depression. There is a need to reduce depression by supporting and advising sufferers. The aim of this study is to evaluate pharmacist counseling's impact on pregnancy rates in depressed infertile females during IVF treatment.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
150

participants targeted

Target at P75+ for not_applicable

Timeline
Completed

Started Jan 2022

Shorter than P25 for not_applicable

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

January 1, 2022

Completed
6 months until next milestone

Primary Completion

Last participant's last visit for primary outcome

July 1, 2022

Completed
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

July 1, 2022

Completed
1.2 years until next milestone

First Submitted

Initial submission to the registry

August 25, 2023

Completed
11 days until next milestone

First Posted

Study publicly available on registry

September 5, 2023

Completed
Last Updated

September 5, 2023

Status Verified

August 1, 2023

Enrollment Period

6 months

First QC Date

August 25, 2023

Last Update Submit

August 31, 2023

Conditions

Keywords

EducationSupportive carePharmacist

Outcome Measures

Primary Outcomes (1)

  • Pregnancy rate

    The outcome of IVF cycles, as measured by clinical pregnancy rates, was recorded after the intervention

    Baseline, 1-month, 3-month, and 6-month marks following the commencement of treatment.

Secondary Outcomes (2)

  • Fertility Quality of Life.

    Baseline, 1-month, 3-month, and 6-month marks following the commencement of treatment.

  • Depression status

    Baseline, 1-month, 3-month, and 6-month marks following the commencement of treatment.

Study Arms (2)

Group 1

EXPERIMENTAL

The study included 75 patients in the intervention group who received an educational and supportive program designed by a clinical pharmacist. The intervention group received support through five visits: at admission, monitoring medication, monitoring ovulation, monitoring harmful effects, providing emotional support, and following up after egg retrieval during embryo transfer.

Behavioral: Educational and supportive care

Group 2

NO INTERVENTION

The control group included 75 infertile married ladies attending the hospital for the same purpose and managed in the traditional protocol followed by the hospital system. The study assessed the fertility quality of life and depression status of the patients at the beginning and end of the IVF cycle. All patients received frozen embryo transfers (fertilized eggs), not fresh embryos.

Interventions

The trial had a total of 75 participants assigned to the intervention group, whereby they were provided with an educative and supporting program specifically developed by a clinical pharmacist. The intervention group was provided with assistance via a series of five visits, which included an initial visit upon admission, subsequent visits for monitoring medication, ovulation, and negative effects, as well as visits dedicated to giving emotional support. Additionally, a follow-up visit was conducted after the egg collecting process and embryo transfer.

Group 1

Eligibility Criteria

Age18 Years - 45 Years
Sexfemale(Gender-based eligibility)
Gender Eligibility DetailsTo be an infertile lady
Healthy VolunteersNo
Age GroupsAdult (18-64)

You may qualify if:

  • To be an infertile lady who spent at least one year after marriage failing to get pregnant and who should then undergo the IVF cycle.
  • To be within the reproductive age (18-45 years old); the success rates of IVF tend to decline with increasing age\[4\].
  • To have the ability to read and understand.
  • Have depression

You may not qualify if:

  • Patient with previous failure of I.V.F. procedure.
  • Very obese (BMI \> 40)\[37\].
  • Patient with psychiatric problems (psychiatric hospital admission, addiction, neurological or other progressive disease, and psychiatric drug use).
  • A patient who has a situation that prevents communication (language and hearing problems).

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

College of Pharmacy, Mustansiriyah University

Baghdad, 10011, Iraq

Location

Related Publications (3)

  • Maleki-Saghooni N, Amirian M, Sadeghi R, Latifnejad Roudsari R. Effectiveness of infertility counseling on pregnancy rate in infertile patients undergoing assisted reproductive technologies: A systematic review and meta-analysis. Int J Reprod Biomed. 2017 Jul;15(7):391-402.

    PMID: 29177241BACKGROUND
  • Al-Homaidan HT. Depression among Women with Primary Infertility attending an Infertility Clinic in Riyadh, Kingdom of Saudi Arabia: Rate, Severity, and Contributing Factors. Int J Health Sci (Qassim). 2011 Jul;5(2):108-15.

    PMID: 23267288BACKGROUND
  • Nkansah N, Mostovetsky O, Yu C, Chheng T, Beney J, Bond CM, Bero L. Effect of outpatient pharmacists' non-dispensing roles on patient outcomes and prescribing patterns. Cochrane Database Syst Rev. 2010 Jul 7;2010(7):CD000336. doi: 10.1002/14651858.CD000336.pub2.

    PMID: 20614422BACKGROUND

MeSH Terms

Conditions

Infertility, FemaleDepression

Interventions

Palliative Care

Condition Hierarchy (Ancestors)

Genital Diseases, FemaleFemale Urogenital DiseasesFemale Urogenital Diseases and Pregnancy ComplicationsUrogenital DiseasesGenital DiseasesInfertilityBehavioral SymptomsBehavior

Intervention Hierarchy (Ancestors)

Patient CareTherapeuticsHealth ServicesHealth Care Facilities Workforce and Services

Study Officials

  • Abeer A Rashid, FIBMS

    Al-Mustansiriyah University

    STUDY DIRECTOR

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
NONE
Purpose
TREATMENT
Intervention Model
PARALLEL
Model Details: The study included 75 patients in the intervention group who received an educational and supportive program designed by a clinical pharmacist. The intervention group received support through five visits: at admission, monitoring medication, monitoring ovulation, monitoring harmful effects, providing emotional support, and following up after egg retrieval during embryo transfer.
Sponsor Type
OTHER
Responsible Party
SPONSOR

Study Record Dates

First Submitted

August 25, 2023

First Posted

September 5, 2023

Study Start

January 1, 2022

Primary Completion

July 1, 2022

Study Completion

July 1, 2022

Last Updated

September 5, 2023

Record last verified: 2023-08

Locations